A Study to Evaluate Safety and Feasibility of Robotic Liver Resection
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Robotic liver resection.
- Who it may be relevant to
- Registry conditions: Liver Diseases, Surgery. Basic parameters: 18 years — 80 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- China
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
The robotic surgery system, the most advanced technology in minimally invasive surgery, overcame some shortcomings of laparoscopic surgery and improved the flexibility and precision of liver resection. Several studies have demonstrated that the robotic system was safe and feasible in liver surgery and might be advantageous in complex hepatic vein and hilar dissection, operative bleeding control, and biliary reconstruction. Previous comparative studies found limited evidence for significantly improved outcomes in robotic liver resection (RLR) over laparoscopic liver resection (LLR) or open liver resection (OLR), considering the various degrees of difficulty in liver surgeries. This study aimed to evaluate safety and feasibility of robotic liver resection, by comparing it with LLR or OLR, and gain veritable and relevant data on the benefits of RLR.
Interventions
- Device Robotic liver resection
Liver resection using Da Vinci robotic system
Primary outcome measures
- Postoperative complications [Time frame: with in 90 days after surgery]
- Postoperative hospital stay [Time frame: with in 90 days after surgery]
- Postoperative unplanned reoperation [Time frame: with in 90 days after surgery]
- Unplanned readmission [Time frame: with in 90 days after surgery]
Eligibility criteria
Inclusion criteria
- The patients were diagnosed with a liver tumor.
- The patients underwent robotic liver resection.
Exclusion criteria
- The patients underwent simultaneous malignancy resection of the colorectum or other organs (except gallbladder).
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- N/A
- Model
- Single group
- Masking
- Open label
- Primary purpose
- Treatment
Study locations
China · 1 center
- First Affiliated Hospital, Medical College of Zhejiang University — Hangzhou
Identifiers
NCT: NCT06353672 · RLR-01